These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 7737354

  • 1. The function of inducible promoter systems in F9 embryonal carcinoma cells.
    Miller K, Rizzino A.
    Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
    [Abstract] [Full Text] [Related]

  • 2. Constitutive expression of fibroblast growth factor-4 does not alter the growth or the differentiation of embryonal carcinoma cells.
    Miller K, Rizzino A.
    Cell Growth Differ; 1996 Feb; 7(2):203-11. PubMed ID: 8822204
    [Abstract] [Full Text] [Related]

  • 3. The vimentin promoter as a tool to analyze the early events of retinoic acid-induced differentiation of cultured embryonal carcinoma cells.
    Benazzouz A, Duprey P.
    Differentiation; 1999 Nov; 65(3):171-80. PubMed ID: 10631814
    [Abstract] [Full Text] [Related]

  • 4. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
    Boer B, Bernadt CT, Desler M, Wilder PJ, Kopp JL, Rizzino A.
    J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
    [Abstract] [Full Text] [Related]

  • 5. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
    Bonovich MT, List HJ, Zhang S, Danielsen M, Riegel AT.
    Exp Cell Res; 1998 Mar 15; 239(2):454-62. PubMed ID: 9521864
    [Abstract] [Full Text] [Related]

  • 6. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E, Cato AC.
    Cell Mol Biol Res; 1994 Mar 15; 40(7-8):643-52. PubMed ID: 7787882
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Highly controlled heterologous gene expression through combined utilization of the tetracycline-repressible transactivator and the lac repressor.
    Hoshikawa Y, Amimoto K, Mizuguchi R, Hatakeyama M.
    Anal Biochem; 1998 Aug 01; 261(2):211-8. PubMed ID: 9716424
    [Abstract] [Full Text] [Related]

  • 10. The murine Hoxb1 3' RAIDR5 enhancer contains multiple regulatory elements.
    Thompson JR, Huang DY, Gudas LJ.
    Cell Growth Differ; 1998 Dec 01; 9(12):969-81. PubMed ID: 9869297
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements.
    Liu HS, Scrable H, Villaret DB, Lieberman MA, Stambrook PJ.
    Cancer Res; 1992 Feb 15; 52(4):983-9. PubMed ID: 1737361
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal.
    Yoshida Y, Hamada H.
    Biochem Biophys Res Commun; 1997 Jan 13; 230(2):426-30. PubMed ID: 9016796
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the human MSX-1 promoter and an enhancer responsible for retinoic acid induction.
    Shen R, Chen Y, Huang L, Vitale E, Solursh M.
    Cell Mol Biol Res; 1994 Jan 13; 40(4):297-312. PubMed ID: 7866431
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.